dm+d

55830003

Refrigerated Storage

MenopurFerring Pharmaceuticals

Ferring Pharmaceuticals
Menopur
Powder and solvent for solution for injection (600 and 1200 IU)

Contact Ferring (UK) in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.

Do not freeze. Keep in the original container in order to protect from light.

27 December 2019
London MI Service

New Medicines

Menopur Male and female infertility - pre-filled pen formulation

Information

Menopur
New formulation
Ferring
Ferring

Development and Regulatory status

Approved (Licensed)
Pre-registration (Filed)
Phase III Clinical Trials
Jun 21Approved by MHRA for the treatment of female and male infertility [4].
Dec 20Also filed in the EU. Remains PIII in US [3].
Jul 20Currently pre-registration in UK. Two strengths of the solution for injection in a pre-filled pen have been filed (600iu and 1200iu) [2].

Category

A gonadotrophin extracted from the urine of postmenopausal women. It has both luteinising hormone and follicle stimulating hormone activity in a 1:1 ratio.
It is estimated that infertility affects 1 in 7 heterosexual couples in the UK. Main causes of infertility in the UK are unexplained infertility (no identified male or female cause) (25%), ovulatory disorders (25%), tubal damage (20%), factors in the male causing infertility (30%) and uterine or peritoneal disorders (10%) [1].
Male and female infertility - pre-filled pen formulation
Subcutaneous injection